InvestSMART

Osteopore Limited (ASX: OSX) - Announcements

- Current share price for OSX : $0.004

ASX company news and announcements for Osteopore Limited (OSX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Osteopore Limited (OSX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Osteopore Limited (OSX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Osteopore Limited (OSX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Activities Update Qtr Ending March 2022 and Appendix 4C 29 Apr 2022 7:58AM $0.190 $0.004 fallen by 97.89%
$3 Appointment of Chief Operating Officer 28 Apr 2022 9:53AM $0.200 $0.004 fallen by 98%
$3 OSX Expands Further into Europe with Initial Sales to Spain 14 Apr 2022 9:18AM $0.195 $0.004 fallen by 97.95%
$3 Annual General Meeting Date 7 Apr 2022 7:05PM $0.210 $0.004 fallen by 98.10%
$3 OSX Expands to Latin America with Initial Sales to Colombia 7 Apr 2022 9:39AM $0.185 $0.004 fallen by 97.84%
$3 Appendix 4G and Corporate Governance Statement 31 Mar 2022 8:06PM $0.175 $0.004 fallen by 97.71%
$3 Annual Report to shareholders 31 Mar 2022 8:06PM $0.175 $0.004 fallen by 97.71%
$3 OSX Commences AI-Powered Design Study for Cranial Implants 14 Mar 2022 9:27AM $0.180 $0.004 fallen by 97.78%
$3 SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures 14 Mar 2022 8:19AM $0.180 $0.004 fallen by 97.78%
$3 Appendix 4E Preliminary Final Report 28 Feb 2022 8:06PM $0.200 $0.004 fallen by 98%
$3 Notification of cessation of securities - OSX 25 Feb 2022 8:08PM $0.200 $0.004 fallen by 98%
$3 Appendix 3Y 25 Feb 2022 8:08PM $0.200 $0.004 fallen by 98%
$3 Appendix 3Z 15 Feb 2022 6:35PM $0.225 $0.004 fallen by 98.22%
$3 Resignation of Non-Executive Director 15 Feb 2022 6:34PM $0.225 $0.004 fallen by 98.22%
$3 Activities Update Qtr Ending December 2021 and Appendix 4C 28 Jan 2022 10:09AM $0.230 $0.004 fallen by 98.26%
$3 Chief Financial Officer Resignation 18 Jan 2022 10:04AM $0.280 $0.004 fallen by 98.57%
$3 Appendix 3X 29 Dec 2021 9:52AM $0.220 $0.004 fallen by 98.18%
$3 Change to the Board of Directors 29 Dec 2021 9:52AM $0.220 $0.004 fallen by 98.18%
$3 Osteopore secures A$19m clinical-industrial partnership 13 Dec 2021 10:51AM $0.210 $0.004 fallen by 98.10%
$3 Osteopore Receives Approval for Hong Kong Sales 2 Dec 2021 9:13AM $0.230 $0.004 fallen by 98.26%
$3 Investor Presentation 22 Nov 2021 10:10AM $0.225 $0.004 fallen by 98.22%
$3 Osteopore granted patent in China opening local opportunity 2 Nov 2021 8:35AM $0.235 $0.004 fallen by 98.30%
$3 Activities Update Qtr Ending September 2021 and Appendix 4C 29 Oct 2021 11:28AM $0.245 $0.004 fallen by 98.37%
$3 Osteopore collaborates with Singular Health Group 19 Oct 2021 9:21AM $0.285 $0.004 fallen by 98.60%
$3 SHG: CSIRO Collaboration for AI-based Tool 19 Oct 2021 8:24AM $0.285 $0.004 fallen by 98.60%

401 - 425 of 517 results

Page 17 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.